KoBioLabs, Inc (KOSDAQ:348150)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Health Functional Food Division			33.14B	11.61B	2.89B	4.59B	576.52M
Health Functional Food Division Growth			185.54%	301.12%	-36.98%	696.42%	798.53%
Total			33.14B	11.61B	2.89B	4.59B	576.52M
Total Growth			185.54%	301.12%	-36.98%	696.42%	798.53%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
South Korea			32.57B	10.67B	2.67B	4.59B	576.52M
South Korea Growth			205.23%	299.97%	-41.89%	696.42%	798.53%
Overseas			564.22M	933.81M	225.20M	-	-
Overseas Growth			-39.58%	314.67%	-	-	-
Total			33.14B	11.61B	2.89B	4.59B	576.52M
Total Growth			185.54%	301.12%	-36.98%	696.42%	798.53%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 28, 2026

Data Sources Report a data error